glaxosmithkline exp ltd.

Activity value 69 england Buyer&Supplier,Last transaction date: 2024-09-20 Address: 980 great west roadbrentfordmiddlesex gb

Bill of lading data

< 1/15 >
  • Trade date 2024/09/20 B/L No. 6360705
  • Suppliers glaxosmithkline exp ltd. Buyers glaxosmithkline pharma gmbh
  • POLs —— PODs sahar air
  • Supply area Italy Purchas area India
  • Weight —— Amount 577462.22
  • Hs code 30021500 Product tags sol,mepol,ion,mab,powder,cala,injection
  • Product description NUCALA FD 100MG 1X10 ML (MEPOLIZUMAB POWDER FOR SOLUTION FORINJECTION) Expand
+View All

Partners

Total 40

Products

Total 43
  • Products Transactions Per Detail
  • equipped with fixed dose drug
    19 30.65% >
  • lutein
    16 25.81% >
  • medicine
    10 16.13% >
  • veterinary drug
    10 16.13% >
  • sol
    4 6.45% >
  • +View All

Hscode rank

Total 35
  • HSCode Name Transactions Per Detail
  • HS 3004900002 19 30.65% >
  • HS 3004320009 16 25.81% >
  • HS 3004100008 10 16.13% >
  • HS 29411090 5 8.06% >
  • HS 30021500 4 6.45% >
  • +View All

Trading Area

Total 12
  • Area Transactions Per Detail
  • kazakhstan 236 29.65% >
  • uzbekistan 182 22.86% >
  • united states 136 17.09% >
  • india 106 13.32% >
  • ecuador 20 2.51% >
  • +View All

Port statistics

Total 27
  • Port Name Transactions Per Detail
  • le havre 62 7.79% >
  • coryton 48 6.03% >
  • felixstowe 28 3.52% >
  • hamble 14 1.76% >
  • hamburg 13 1.63% >
  • +View All
glaxosmithkline exp ltd. is england Buyer&Supplier,  and primarily engages in the import and export business of products such as equipped with fixed dose drug,lutein,medicine.  According to the 52wmb.com global trade database, as of 2024-09-20, the company has completed 796 international trades,  with its main trading regions covering kazakhstan,uzbekistan,united states etc.  The core products include HS3004900002,HS3004320009,HS3004100008 etc,  often transported via le havre,port coryton, port felixstowe etc,  and its main trading partners are тоо гск казахстан,ooo curatio pharm,glaxosmithkline pharma gmbh.  These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.  They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development. They provide reliable support for cross-border trade decision-making.
The trade data displayed on glaxosmithkline exp ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis. We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.

Reference contact info


Email Hunting Tool

Whatsapp:+8616621075894(9:00 Am-18:00 Pm (SGT))

About us Contact us Advertise Buyer Supplier Company report Industry report

©2010-2026 52wmb.com all rights reserved